Online R&D and Business Tracker for Bispecific Antibodies

DUBLIN, August 16, 2017 /PRNewswire/ --

The "R&D and Business Tracker for Bispecific Antibodies" newsletter has been added to Research and Markets' offering.

This information service about Bispecific Antibodies delivers 12 monthly update reports in pdf format by e-mail straight to your desk and provides online access to the author's R&D database for the subject field of the service during the one-year subscription period. Credentials to access the online database will be sent by e-mail within 24 hours after purchase.

This product consists of:

- 12 monthly update reports in pdf format delivered by e-mail- online access to Bispecific Antibody R&D database during the 1-year subscription period

The R&D and Business Tracker for Bispecific Antibodies covers;

- T-Cell redirecting bispecific cancer antibodies- NK cell redirecting bispecific cancer antibodies- Bispecific immuno-oncology antibodies- Bispecific tumor antigens targeted cancer antibodies- Bispecific antibodies for inflammatory & autoimmune diseases- Bispecific antibodies for cardiometabolic, infectious, neurologic, ophthalmic or pulmonary diseasesThe monthly update report about Bispecific Antibodies contains:

R&D and Technology Tracker

- Pipeline changes- Regulatory news- Technology validations

Business Tracker for:

- Company updates

- Collaboration

- Licensing

- Merger & acquisitions

- Financing

Clinical Trial Tracker

Scientific Publication Tracker

Featured Bispecific Antibody or Technology Profile

Featured Company Profile

Featured Target or Technology Pipeline

For more information about this newsletter visit https://www.researchandmarkets.com/research/rqcpqr/randd_and

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716